FDA — authorised 13 February 1973
- Marketing authorisation holder: APOTHECON
- Status: approved
🇺🇸 Kanacin in United States
FDA authorised Kanacin on 13 February 1973
Marketing authorisations
FDA — authorised 5 November 1981
- Application: ANDA062324
- Marketing authorisation holder: HIKMA
- Local brand name: KANAMYCIN
- Indication: INJECTABLE — INJECTION
- Status: approved
Kanacin in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Metabolic approved in United States
Frequently asked questions
Is Kanacin approved in United States?
Yes. FDA authorised it on 13 February 1973; FDA authorised it on 5 November 1981.
Who is the marketing authorisation holder for Kanacin in United States?
APOTHECON holds the US marketing authorisation.